NO20022456L - Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon - Google Patents
Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjonInfo
- Publication number
- NO20022456L NO20022456L NO20022456A NO20022456A NO20022456L NO 20022456 L NO20022456 L NO 20022456L NO 20022456 A NO20022456 A NO 20022456A NO 20022456 A NO20022456 A NO 20022456A NO 20022456 L NO20022456 L NO 20022456L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- alkyl
- compounds
- membered
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9927874.9A GB9927874D0 (en) | 1999-11-25 | 1999-11-25 | Therapeutic agents |
GB0009602A GB0009602D0 (en) | 2000-04-18 | 2000-04-18 | Therapeutic agents |
GB0018651A GB0018651D0 (en) | 2000-07-28 | 2000-07-28 | Therapeutic agents |
PCT/GB2000/004450 WO2001038331A2 (en) | 1999-11-25 | 2000-11-22 | Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20022456L true NO20022456L (no) | 2002-05-24 |
NO20022456D0 NO20022456D0 (no) | 2002-05-24 |
Family
ID=27255677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20022456A NO20022456D0 (no) | 1999-11-25 | 2002-05-24 | Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon |
Country Status (20)
Country | Link |
---|---|
US (1) | US6355638B1 (es) |
EP (1) | EP1235829A2 (es) |
JP (1) | JP2003514909A (es) |
KR (1) | KR20020053091A (es) |
CN (1) | CN1391574A (es) |
AU (1) | AU1533001A (es) |
BG (1) | BG106734A (es) |
BR (1) | BR0015126A (es) |
CA (1) | CA2391103A1 (es) |
CZ (1) | CZ20021813A3 (es) |
EA (1) | EA200200599A1 (es) |
EE (1) | EE200200260A (es) |
HK (1) | HK1046406A1 (es) |
HU (1) | HUP0203579A3 (es) |
IL (1) | IL149051A0 (es) |
MX (1) | MXPA02005233A (es) |
NO (1) | NO20022456D0 (es) |
PL (1) | PL355637A1 (es) |
SK (1) | SK8952002A3 (es) |
WO (1) | WO2001038331A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
EP2298296A1 (en) * | 2009-08-25 | 2011-03-23 | CNRS Centre National De La Recherche Scientifique | Composition and method for treating cognitive impairments in down syndrome subjects |
NZ603789A (en) * | 2010-05-26 | 2015-03-27 | Sunovion Pharmaceuticals Inc | Heteroaryl compounds and methods of use thereof |
US20150374705A1 (en) * | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
CN107344938B (zh) * | 2016-05-06 | 2022-05-06 | 上海赛默罗生物科技有限公司 | 吡唑-三嗪类衍生物、其制备方法、药物组合物和用途 |
CN107344936B (zh) * | 2016-05-06 | 2022-06-03 | 上海赛默罗生物科技有限公司 | 三唑哒嗪类衍生物、其制备方法、药物组合物和用途 |
PE20220901A1 (es) * | 2019-06-19 | 2022-05-30 | Biomarin Pharm Inc | Inhibidores de glicolato oxidasa para el tratamiento de enfermedades |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SK9399A3 (en) * | 1996-07-25 | 2000-04-10 | Merck Sharp & Dohme | Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
GB9715977D0 (en) * | 1997-07-29 | 1997-10-01 | Merck Sharp & Dohme | Therapeutic agents |
US6303597B1 (en) * | 1998-01-14 | 2001-10-16 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for GABA receptors |
GB9806102D0 (en) * | 1998-03-20 | 1998-05-20 | Merck Sharp & Dohme | Therapeutic agents |
US6479506B1 (en) * | 1998-06-16 | 2002-11-12 | Merck Sharp & Dohme Ltd. | Triazolo-pyridine derivatives as ligands for GABA receptors |
DE69936998T2 (de) * | 1998-10-16 | 2008-05-21 | Merck Sharp & Dohme Ltd., Hoddesdon | Pyrazolotriazinderivate als gaba-rezeptorliganden |
-
2000
- 2000-11-21 US US09/717,423 patent/US6355638B1/en not_active Expired - Lifetime
- 2000-11-22 CZ CZ20021813A patent/CZ20021813A3/cs unknown
- 2000-11-22 IL IL14905100A patent/IL149051A0/xx unknown
- 2000-11-22 EP EP00977692A patent/EP1235829A2/en not_active Withdrawn
- 2000-11-22 JP JP2001540094A patent/JP2003514909A/ja not_active Withdrawn
- 2000-11-22 PL PL00355637A patent/PL355637A1/xx not_active Application Discontinuation
- 2000-11-22 SK SK895-2002A patent/SK8952002A3/sk unknown
- 2000-11-22 BR BR0015126-2A patent/BR0015126A/pt not_active Application Discontinuation
- 2000-11-22 MX MXPA02005233A patent/MXPA02005233A/es not_active Application Discontinuation
- 2000-11-22 CA CA002391103A patent/CA2391103A1/en not_active Abandoned
- 2000-11-22 KR KR1020027006672A patent/KR20020053091A/ko not_active Application Discontinuation
- 2000-11-22 CN CN00816013A patent/CN1391574A/zh active Pending
- 2000-11-22 WO PCT/GB2000/004450 patent/WO2001038331A2/en not_active Application Discontinuation
- 2000-11-22 HU HU0203579A patent/HUP0203579A3/hu unknown
- 2000-11-22 EA EA200200599A patent/EA200200599A1/ru unknown
- 2000-11-22 AU AU15330/01A patent/AU1533001A/en not_active Abandoned
- 2000-11-22 EE EEP200200260A patent/EE200200260A/xx unknown
-
2002
- 2002-05-22 BG BG106734A patent/BG106734A/xx unknown
- 2002-05-24 NO NO20022456A patent/NO20022456D0/no not_active Application Discontinuation
- 2002-10-29 HK HK02107821.8A patent/HK1046406A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
SK8952002A3 (en) | 2002-10-08 |
MXPA02005233A (es) | 2002-11-07 |
EE200200260A (et) | 2003-06-16 |
HK1046406A1 (zh) | 2003-01-10 |
PL355637A1 (en) | 2004-05-04 |
AU1533001A (en) | 2001-06-04 |
EP1235829A2 (en) | 2002-09-04 |
CZ20021813A3 (cs) | 2002-08-14 |
BR0015126A (pt) | 2002-07-02 |
HUP0203579A3 (en) | 2003-07-28 |
US6355638B1 (en) | 2002-03-12 |
WO2001038331A3 (en) | 2001-11-08 |
HUP0203579A2 (hu) | 2003-03-28 |
BG106734A (en) | 2003-02-28 |
WO2001038331A2 (en) | 2001-05-31 |
IL149051A0 (en) | 2002-11-10 |
NO20022456D0 (no) | 2002-05-24 |
EA200200599A1 (ru) | 2002-12-26 |
JP2003514909A (ja) | 2003-04-22 |
CA2391103A1 (en) | 2001-05-31 |
CN1391574A (zh) | 2003-01-15 |
KR20020053091A (ko) | 2002-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE73815T1 (de) | Adenosin-derivate und pharmazeutische zusammenstellungen, welche diese als aktiven bestandteil enthalten. | |
ATE448226T1 (de) | Aza heterocyclische derivate und ihre therapeutische verwendung | |
EA200601235A1 (ru) | Производные тиазола | |
NO173446C (no) | Analogifremgangsmaate til fremstilling av nye, terapeutisk aktive, substituerte alkandifosfonsyrer | |
NO20050418L (no) | Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet | |
DE60140860D1 (de) | 2-aminonicotinamid-derivate und ihre verwendung als vegf-rezeptor tyrosin-kinase inhibitoren | |
BR9908764A (pt) | Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica | |
BR9916781A (pt) | 4-oxo-1,4-dihidro-3-quinolinacarboxamidas comoagentes antivirais | |
HUP9902340A2 (hu) | Kondenzált piridinek és pirimidinek aril-amino-származékai, eljárás előállításukra, valamint e vegyületeket tartalmazó gyógyászati készítmények, továbbá e vegyületek alkalmazása | |
BR0015193A (pt) | Composto, composição farmacêutica, uso de um composto, e, método para tratamento de uma condição associada com trasmissão reduzida de nicotina, para tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para tratamento ou profilaxia de doenças ou condições humanas | |
BR0111754A (pt) | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica | |
YU49443B (sh) | Derivati benzimidazola, postupci za njihovo pripremanje i primena tih derivata u medicinskoj terapiji, naročito za lečenje ili sprečavanje virusnih infekcija | |
ES8802518A1 (es) | Un procedimiento para preparar derivados de isoxazol y furano. | |
ATE74132T1 (de) | Imid-derivate, ihre herstellung und ihre verwendung. | |
BR0015195A (pt) | Composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento de uma condição associada com a transmissão reduzida de nicotina para o tratamento ou profilaxia de distúrbios psicóticos ou distúrbios de deterioração intelectual e para o tratamento ou profilaxia de doenças ou condições humanas | |
NO981241L (no) | Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse | |
NO20022456L (no) | Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon | |
ATE92489T1 (de) | Imid-derivate, ihre herstellung und verwendung. | |
AU7810787A (en) | 6-{2-(3-phenoxy-2-hydroxy-propylamino)-propyl-amino}-5- methyl-pyrizine-3-one derivatives useful as antihyper- tensive agents | |
NO20051833L (no) | 4-(3,5-dicyanofenoksy)pyrazolderivater for anvendelse som transkriptasemodulatorer ved behandling av IA HIV. | |
ATE325790T1 (de) | Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung | |
DE69017855D1 (de) | Oxetan-Derivate, ihre Herstellung und ihre Verwendung als Anti-Fungal oder fungizides Mittel. | |
DK159924C (da) | Pyridooe1,2-aaapyrimidinderivater, fremgangsmaade til deres fremstilling samt farmaceutisk praeparat til behandling af allergiske sygdomme indeholdende derivaterne | |
EP0299076A4 (en) | 5-hydroxyindole-3-carboxamide compound and medicinal use thereof | |
ES2053580T3 (es) | Derivados de pirido(4,3-d)pirimidina. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |